08 Sep 2023
18:00 CEST |
PHAXIAM THERAPEUTICS |
Monthly information related to total number of voting rights and shares composing the share capital _August 31, 2023
|
20103010 Biotechnology |
Legal |
08 Sep 2023
18:00 CEST |
PHAXIAM THERAPEUTICS |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 août 2023
|
20103010 Biotechnology |
Legal |
05 Sep 2023
22:05 CEST |
PHAXIAM THERAPEUTICS |
PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences
|
20103010 Biotechnology |
Meetings / events |
05 Sep 2023
22:05 CEST |
PHAXIAM THERAPEUTICS |
PHAXIAM Therapeutics publie son niveau de trésorerie, son nouveau calendrier financier et annonce sa participation à de prochaines conférences investisseurs
|
20103010 Biotechnology |
Meetings / events |
08 Aug 2023
18:00 CEST |
PHAXIAM THERAPEUTICS |
Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2023
|
20103010 Biotechnology |
Legal |
08 Aug 2023
18:00 CEST |
PHAXIAM THERAPEUTICS |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2023
|
20103010 Biotechnology |
Legal |
27 Jul 2023
22:05 CEST |
PHAXIAM THERAPEUTICS |
PHAXIAM Therapeutics annonce le regroupement de ses actions
|
20103010 Biotechnology |
Share history |
27 Jul 2023
22:05 CEST |
PHAXIAM THERAPEUTICS |
PHAXIAM Therapeutics announces a reverse share split of its shares
|
20103010 Biotechnology |
Share history |
28 Jun 2023
22:05 CEST |
ERYTECH PHARMA |
Phaxiam Therapeutics annonce son nouveau code mnémonique sur Euronext et Nasdaq : PHXM
|
20103010 Biotechnology |
Corporate life |
28 Jun 2023
22:05 CEST |
ERYTECH PHARMA |
Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM
|
20103010 Biotechnology |
Corporate life |
27 Jun 2023
18:00 CEST |
ERYTECH PHARMA |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 26 juin 2023
|
20103010 Biotechnology |
Legal |
27 Jun 2023
18:00 CEST |
ERYTECH PHARMA |
Monthly information related to total number of voting rights and shares composing the share capital - June 26, 2023
|
20103010 Biotechnology |
Legal |
26 Jun 2023
22:05 CEST |
ERYTECH PHARMA |
ERYTECH et PHERECYDES annoncent leur fusion pour former PHAXIAM Therapeutics
|
20103010 Biotechnology |
Corporate life |
26 Jun 2023
22:05 CEST |
ERYTECH PHARMA |
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
|
20103010 Biotechnology |
Corporate life |
23 Jun 2023
22:30 CEST |
ERYTECH PHARMA |
ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023
|
20103010 Biotechnology |
General meeting / Board Meeting |
23 Jun 2023
22:30 CEST |
ERYTECH PHARMA |
ERYTECH annonce l'approbation de la fusion avec Pherecydes et communique les résultats de l'Assemblée Générale Mixte du 23 juin 2023
|
20103010 Biotechnology |
General meeting / Board Meeting |
20 Jun 2023
22:05 CEST |
ERYTECH PHARMA |
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit
|
20103010 Biotechnology |
Other subject |
20 Jun 2023
22:05 CEST |
ERYTECH PHARMA |
ERYTECH annonce qu'Akkadian poursuit sa tentative de déstabilisation avec l'introduction d'une nouvelle action judiciaire
|
20103010 Biotechnology |
Other subject |
14 Jun 2023
20:00 CEST |
ERYTECH PHARMA |
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma
|
20103010 Biotechnology |
Other subject |
14 Jun 2023
20:00 CEST |
ERYTECH PHARMA |
ERYTECH annonce que le tribunal de commerce a débouté Akkadian de sa demande de report du vote sur la fusion avec Pherecydes Pharma
|
20103010 Biotechnology |
Other subject |
13 Jun 2023
18:00 CEST |
ERYTECH PHARMA |
Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2023
|
20103010 Biotechnology |
Legal |
13 Jun 2023
18:00 CEST |
ERYTECH PHARMA |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2023
|
20103010 Biotechnology |
Legal |
12 Jun 2023
07:00 CEST |
ERYTECH PHARMA |
ERYTECH répond à la désinformation d’Akkadian
|
20103010 Biotechnology |
Other subject |
12 Jun 2023
07:00 CEST |
ERYTECH PHARMA |
ERYTECH Responds to Akkadian’s Disinformation
|
20103010 Biotechnology |
Other subject |
05 Jun 2023
08:00 CEST |
ERYTECH PHARMA |
ERYTECH annonce qu’Akkadian a initié une procédure visant à obtenir le report du vote de la fusion avec Pherecydes
|
20103010 Biotechnology |
Alliances and agreements |
05 Jun 2023
08:00 CEST |
ERYTECH PHARMA |
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes
|
20103010 Biotechnology |
Alliances and agreements |
24 May 2023
22:05 CEST |
ERYTECH PHARMA |
ERYTECH annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 23 juin 2023
|
20103010 Biotechnology |
General meeting / Board Meeting |
24 May 2023
22:05 CEST |
ERYTECH PHARMA |
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023
|
20103010 Biotechnology |
General meeting / Board Meeting |
23 May 2023
22:05 CEST |
ERYTECH PHARMA |
ERYTECH annonce la mise à disposition du document d'exemption relatif au projet de rapprochement avec Pherecydes
|
20103010 Biotechnology |
Alliances and agreements |
23 May 2023
22:05 CEST |
ERYTECH PHARMA |
ERYTECH announces the availability of the exemption document relating to the proposed combination with Pherecydes
|
20103010 Biotechnology |
Alliances and agreements |
16 May 2023
18:00 CEST |
ERYTECH PHARMA |
Monthly information related to total number of voting rights and shares composing the share capital _May 15, 2023
|
20103010 Biotechnology |
Legal |
16 May 2023
18:00 CEST |
ERYTECH PHARMA |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 15 mai 2023
|
20103010 Biotechnology |
Legal |
15 May 2023
22:45 CEST |
ERYTECH PHARMA |
ERYTECH Provides Update on the Announced Combination with PHERECYDES
|
20103010 Biotechnology |
Alliances and agreements |
15 May 2023
22:45 CEST |
ERYTECH PHARMA |
Point d'étape sur le rapprochement entre ERYTECH et PHERECYDES
|
20103010 Biotechnology |
Alliances and agreements |
12 May 2023
18:00 CEST |
ERYTECH PHARMA |
Monthly information related to total number of voting rights and shares composing the share capital _April 30, 2023
|
20103010 Biotechnology |
Other subject |
12 May 2023
18:00 CEST |
ERYTECH PHARMA |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2023
|
20103010 Biotechnology |
Other subject |
09 May 2023
08:00 CEST |
ERYTECH PHARMA |
ERYTECH Provides Business and Financial Update for the First Quarter of 2023
|
20103010 Biotechnology |
Income |
09 May 2023
08:00 CEST |
ERYTECH PHARMA |
ERYTECH fait le point sur ses activités et sa position financière pour le premier trimestre 2023
|
20103010 Biotechnology |
Income |
17 Apr 2023
22:05 CEST |
ERYTECH PHARMA |
ERYTECH annonce l'approbation du transfert de sa cotation vers le Nasdaq Capital Market
|
20103010 Biotechnology |
Share history |
17 Apr 2023
22:05 CEST |
ERYTECH PHARMA |
ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market
|
20103010 Biotechnology |
Share history |
12 Apr 2023
18:00 CEST |
ERYTECH PHARMA |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mars 2023
|
20103010 Biotechnology |
Legal |
12 Apr 2023
18:00 CEST |
ERYTECH PHARMA |
Monthly information related to total number of voting rights and shares composing the share capital _March 31, 2023
|
20103010 Biotechnology |
Legal |
22 Mar 2023
22:05 CET |
ERYTECH PHARMA |
ERYTECH fait le point sur ses activités et publie ses résultats du quatrième trimestre et de l’année 2022
|
20103010 Biotechnology |
Income |
22 Mar 2023
22:05 CET |
ERYTECH PHARMA |
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
|
20103010 Biotechnology |
Income |
06 Mar 2023
18:00 CET |
ERYTECH PHARMA |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 28 février 2023
|
20103010 Biotechnology |
Legal |
06 Mar 2023
18:00 CET |
ERYTECH PHARMA |
Monthly information related to total number of voting rights and shares composing the share capital _February 28, 2023
|
20103010 Biotechnology |
Legal |
15 Feb 2023
22:30 CET |
ERYTECH PHARMA |
ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies
|
20103010 Biotechnology |
Other subject |
15 Feb 2023
22:30 CET |
ERYTECH PHARMA |
ERYTECH et PHERECYDES annoncent un projet de rapprochement stratégique en vue de créer un leader mondial de la phagothérapie
|
20103010 Biotechnology |
Other subject |
09 Feb 2023
18:00 CET |
ERYTECH PHARMA |
Monthly information related to total number of voting rights and shares composing the share capital _January 31, 2023
|
20103010 Biotechnology |
Legal |
09 Feb 2023
18:00 CET |
ERYTECH PHARMA |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2023
|
20103010 Biotechnology |
Legal |